SLC5A2 and type 1 diabetes mellitus: <h4>Introduction</h4>We report a case series of severe ketoacidosis after COVID-19 vaccination in a type 1 diabetes patients treated with insulin and an SGLT-2 inhibitor.<h4>Case report</h4>We present two cases of type 1 diabetes mellitus.